August 13, 2021
1 min read

Decision on Covaxin emergency authorisation expected by Sept: MEA

The World Health Organisation has said the agency expects to make a decision next month on an emergency authorisation for the Indian-made COVID-19 vaccine….reports Asian Lite News

The Ministry of External Affairs (MEA) on Thursday said a decision on emergency authorisation for the Covaxin Covid-19 vaccine made by Bharat Biotech is expected to be announced by September as the World Health Organisation (WHO) takes 6-8 weeks to grant the emergency use listing.

In a media briefing, MEA spokesperson Arindam Bagchi said, “Covaxin submitted its application on July 9 so we are expecting a response by September as it takes 6-8 weeks for the WHO to grant the EUL.”

External Affairs Minister S Jaishankar had made a similar statement at the CII annual event.

The World Health Organisation has said the agency expects to make a decision next month on an emergency authorisation for the Indian-made COVID-19 vaccine.

Last week, Bharat Biotech’s Covaxin received a Good Manufacturing Practices (GMP) compliance certificate from Hungary. The certificate of GMP is now listed on the EudraGMDP database which is the collection of records of the European Community of manufacturing authorisations and certificates of good manufacturing practice, Bharat Biotech said.

Asked about the actions taken by the government on easing Covid travel restrictions, the MEA Spokesperson said, “There are many countries where Covid restrictions are there. Not just students, other people who would like to travel are facing problems. As I have said earlier, we attach high importance to ensuring ease of these restrictions whether they live abroad for education or employment. We have been actively taking up this matter at various levels including at the ministerial levels with all of the countries. I am happy to see some forward movements with some of the countries. MEA will continue to attach high priority to this issue.” (India News Network)

ALSO READ: No compromise on Covaxin quality, says Bharat Biotech

ALSO READ: Nod for proposal to study mixing of Covid-19 vaccine doses

Previous Story

Mayor, film industry urge Londoners ‘Back to the Big Screen’

Next Story

Right to shelter doesn’t mean govt housing for unlimited period: SC

Latest from -Top News

US Backs India’s Hunt for Pahalgam Terrorists

Gabbard’s “hunt down” message comes amidst escalating Indian response to the terrorist attack, saying it had clear “cross-border” links to Pakistan….reports Asian Lite News Tulsi Gabbard, Director of National Intelligence (DNI), on

Border Sealed, Hopes on Hold

A Hindu family from Balochistan’s Sibi was reportedly denied entry into India after the closure of border crossing….reports Asian Lite News Pakistan and India’s decision to shut down the Wagah-Attari border crossing

West visits Cambodia to strengthen ties 

The visit also addresses shared security concerns, including combating serious organised crime and human trafficking, and future defence cooperation initiatives  The UK and Cambodia are collaborating to advance climate initiatives and promote
Go toTop

Don't Miss

India Strongly Protests UK Envoy’s PoK Visit

British High Commissioner to Pakistan Jane Marriott visited Mirpur city

Modi targets Rahul  in Lok Sabha speech, accuses Cong of speaking lies

PM Modi said Congress should accept the verdict of the